The Effects of Magnesium Supplementation on Lipid Profile Among Type 2 Diabetes Patients: a Systematic Review and Meta-analysis of Randomized Controlled Trials

[1]  S. Maggi,et al.  Epidemiology of Cardiovascular Diseases in the Elderly. , 2020, Advances in experimental medicine and biology.

[2]  W. Oigman,et al.  Effects of Oral Magnesium Supplementation on Vascular Function: A Systematic Review and Meta-analysis of Randomized Controlled Trials , 2019, High Blood Pressure & Cardiovascular Prevention.

[3]  S. Nachvak,et al.  Effects of Spirulina supplementation on obesity: A systematic review and meta-analysis of randomized clinical trials. , 2019, Complementary therapies in medicine.

[4]  R. Caesar,et al.  Dietary lipids, gut microbiota and lipid metabolism , 2019, Reviews in Endocrine and Metabolic Disorders.

[5]  Z. Aslani,et al.  Effects of grape products on blood lipids: a systematic review and dose-response meta-analysis of randomized controlled trials. , 2019, Food & function.

[6]  A. Pasdar,et al.  Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies , 2019, IUBMB life.

[7]  Pardis Kaveh,et al.  Association of serum magnesium level with resistant hyperlipidemia in diabetic and hypertensive patients , 2019, Journal of Nephropharmacology.

[8]  F. Estebsari,et al.  An analytical study of the factors affecting the health promoting lifestyle; comparison of type II diabetic patients with healthy people , 2019, Journal of Renal Injury Prevention.

[9]  F. Ghorat,et al.  The effect of artichoke leaf extract supplementation on lipid profile of chronic kidney disease patients; a double-blind, randomized clinical trial , 2019, Journal of Renal Injury Prevention.

[10]  A. Feizi,et al.  Relationship between Dietary Patterns and Incidence of Type 2 Diabetes , 2019, International journal of preventive medicine.

[11]  A. Hadi,et al.  Effects of silymarin supplementation on blood lipids: A systematic review and meta‐analysis of clinical trials , 2019, Phytotherapy research : PTR.

[12]  Ahmad Esmaillzadeh,et al.  Oral Magnesium Supplementation Improved Lipid Profile but Increased Insulin Resistance in Patients with Diabetic Nephropathy: a Double-Blind Randomized Controlled Clinical Trial , 2019, Biological Trace Element Research.

[13]  M. Mansournia,et al.  Effects of magnesium supplementation on carotid intima–media thickness and metabolic profiles in diabetic haemodialysis patients: a randomised, double-blind, placebo-controlled trial , 2019, British Journal of Nutrition.

[14]  M. Rouhani,et al.  Effect of L-Citrulline Supplementation on Blood Pressure: a Systematic Review and Meta-Analysis of Clinical Trials , 2018, Current Hypertension Reports.

[15]  V. Jonnalagadda,et al.  Effect of Metformin or Chinese Herbal Formula in Patients with Type 2 Diabetes Mellitus and Hyperlipidemia: A Reassessment , 2018, mBio.

[16]  A. Sanagoo,et al.  The prevalence of hypertension in diabetic patients in Iran; a systematic review and meta-analysis , 2018 .

[17]  M. Borggrefe,et al.  Iatrogenicity: Causes and Consequences of Iatrogenesis in Cardiovascular Medicine , 2017 .

[18]  R. Garg,et al.  Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta‐analysis , 2017, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[19]  R. Razzaghi,et al.  Magnesium Supplementation and the Effects on Wound Healing and Metabolic Status in Patients with Diabetic Foot Ulcer: a Randomized, Double-Blind, Placebo-Controlled Trial , 2017, Biological Trace Element Research.

[20]  A. Sahebkar,et al.  Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials , 2017, European Journal of Clinical Pharmacology.

[21]  A. Sharifi,et al.  The Relationship of Maternal Subclinical Hypothyroidism during Pregnancy and Preterm Birth: A Systematic Review and Meta-Analysis of Cohort Studies , 2017 .

[22]  S. Hosseini,et al.  Trends of serum creatinine among patients with type 2 diabetes in Isfahan endocrine and metabolism research center; a longitudinal study , 2016 .

[23]  M. Rodríguez-Moran,et al.  Magnesium in metabolic syndrome: a review based on randomized, double-blind clinical trials. , 2016, Magnesium research.

[24]  M. Barbagallo,et al.  Magnesium and type 2 diabetes. , 2015, World journal of diabetes.

[25]  H. Shirzad,et al.  Antioxidant plants and diabetes mellitus , 2015, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[26]  H. Nasri.  Consequences of hypomagnesemia in type 2 diabetes mellitus patients , 2014, Journal of renal injury prevention.

[27]  Jiming Liu,et al.  Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range , 2014, BMC Medical Research Methodology.

[28]  S. Hosseini,et al.  Oral magnesium supplementation in type II diabetic patients , 2014, Medical journal of the Islamic Republic of Iran.

[29]  F. Hu,et al.  The global implications of diabetes and cancer , 2014, The Lancet.

[30]  F. Guerrero‐Romero,et al.  No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia. , 2014, Magnesium research.

[31]  A. Ahmadi,et al.  Association of serum lipids with level of blood pressure in type 2 diabetic patients , 2013, Journal of renal injury prevention.

[32]  H. Nasri,et al.  Prevention of Hypomagnesemia in Diabetes Patients , 2013, International journal of preventive medicine.

[33]  R. Rostami,et al.  Evaluation of serum magnesium in type II diabetic patients , 2013 .

[34]  F. Zitman,et al.  The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression , 2013, Psychoneuroendocrinology.

[35]  N. Namazi,et al.  The effect of hydro alcoholic nettle (Urtica dioica) extract on oxidative stress in patients with type 2 diabetes: a randomized double-blind clinical trial. , 2012, Pakistan journal of biological sciences : PJBS.

[36]  Parto Nasri,et al.  Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients , 2012, Journal of renal injury prevention.

[37]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[38]  D. Spiegel.  Magnesium in Chronic Kidney Disease: Unanswered Questions , 2011, Blood Purification.

[39]  C. Bias.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials , 2011 .

[40]  F. Turgut,et al.  Magnesium in Chronic Kidney Disease: Challenges and Opportunities , 2010, Blood Purification.

[41]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[42]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[43]  M. Rodríguez-Moran,et al.  The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial , 2009, Journal of Human Hypertension.

[44]  J. Navarro-González,et al.  Reviews: Clinical Implications of Disordered Magnesium Homeostasis in Chronic Renal Failure and Dialysis , 2009, Seminars in dialysis.

[45]  M. Rodríguez-Moran,et al.  Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. , 2008, Magnesium research.

[46]  H. Baradaran,et al.  Lipids in association with serum magnesium in diabetes mellitus patients. , 2008, Bratislavske lekarske listy.

[47]  Raghu Kacker,et al.  Random-effects model for meta-analysis of clinical trials: an update. , 2007, Contemporary clinical trials.

[48]  Chen Hao,et al.  Relationship between dyslipidemia and diabetic retinopathy , 2007 .

[49]  M. Rambeau,et al.  Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach. , 2005, Magnesium research.

[50]  M. Seelig,et al.  Comparison of Mechanism and Functional Effects of Magnesium and Statin Pharmaceuticals , 2004, Journal of the American College of Nutrition.

[51]  M. Rodríguez-Moran,et al.  Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. , 2003, Diabetes care.

[52]  M. Barbagallo,et al.  Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. , 2003, Molecular aspects of medicine.

[53]  H. D. de Valk,et al.  Oral magnesium supplementation in insulin‐requiring Type 2 diabetic patients , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[54]  E. Ravussin,et al.  Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians. , 1995, The Journal of clinical endocrinology and metabolism.

[55]  G. Schernthaner,et al.  Hypomagnesemia in Type II Diabetes: Effect of a 3-Month Replacement Therapy , 1995, Diabetes Care.

[56]  A. Allegra,et al.  Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. , 1994, Magnesium research.

[57]  J. Wang.  [Determination of intraerythrocytic Na+, K+, Ca++, Mg++ and cell-membrane Na+-K+-ATPase activities: its diagnostic value in digoxin poisoning]. , 1987, Zhonghua yi xue za zhi.

[58]  C. Christiansen,et al.  Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis , 1982, European journal of clinical investigation.

[59]  C. Christiansen,et al.  Hypomagnesemia, a Risk Factor in Diabetic Retinopathy , 1978, Diabetes.